EC Dental Science

Conceptual Paper Volume 22 Issue 9 - 2023

Canker and Slobber-Salivary Gland Adenocarcinoma-NOS

Anubha Bajaj*

Department of Histopathology, Panjab University, A.B. Diagnostics, India

*Corresponding Author: Anubha Bajaj, Department of Histopathology, Panjab University, A.B. Diagnostics, India.
Received: August 24, 2023; Published: August 30, 2023



Salivary gland adenocarcinoma not otherwise specified (NOS) represents as an invasive tumefaction demonstrating glandular or ductal differentiation. Generally, tumefaction is devoid of morphological features characteristic of diverse subtypes of malignant salivary gland neoplasms. With a frequently aggressive biological course, salivary gland adenocarcinoma (NOS) comprehensively configures up to 10% of malignant salivary gland tumours. Salivary gland adenocarcinoma (NOS) is essentially a diagnosis of exclusion.

Salivary gland adenocarcinoma (NOS) may metastasize into cervical lymph node (~23%) whereas distant metastases occur within 37% tumours. 5 year disease specific survival emerges at ~57%.

Anubha Bajaj. "Canker and Slobber-Salivary Gland Adenocarcinoma-NOS". EC Dental Science 22.9 (2023): 01-05.